SIG: Real-World Evidence (RWE) Collaborative

 View Only

Survey: Assessing Barriers to Comparative Effectiveness Research (CER)

  • 1.  Survey: Assessing Barriers to Comparative Effectiveness Research (CER)

    Posted 7 days ago

    Dear All,

    We are currently assessing whether the quantity of CER generated within the pharmaceutical research community is sufficient to meet the needs of payers and health authorities in the US, EU and globally. This research aims to determine whether a gap in CER exists based on researcher perceptions within their own organizations and highlight the potential barriers to generating a higher volume of CER studies.

    The survey contains 11 questions and takes approximately 5-10 minutes to complete. The data from the responses will be collected, analyzed, and published along with other findings of the research in a reputable epidemiological journal. The ISPE community's contribution will be acknowledged in the publication.

    We appreciate your support in discovering critical challenges in pharmacoepidemiologic research and in helping advance the field.  

    To participate in the survey, please click on this link:

    Survey: Assessing Barriers to Comparative Effectiveness Research (CER)

    Thank you on behalf of the CER Survey Team!



    ------------------------------
    Daniel Sheinson
    Genentech
    South San Francisco CA
    +1 (650) 303-1372
    ------------------------------